Key Points
- Document the long-term clinical course and therapeutic outcomes of multidecade quinidine treatment in a patient with paroxysmal ventricular tachycardia.
- Reviewed clinical case data of a patient maintained on long-term quinidine therapy who developed a severe myocardial infarction prior to scheduled ureteric surgery.
- Evaluated clinical findings alongside historical antiarrhythmic benchmarks for quinidine and serum level monitoring in supraventricular and ventricular arrhythmias.
- Ureterolysis and ureteric reimplantation were postponed after the patient experienced an acute major myocardial infarction during long-term antiarrhythmic management.
- Historical comparator data cited demonstrated successful conversion to normal sinus rhythm without major adverse effects in 80% of 111 cases of atrial fibrillation and flutter managed through therapeutic blood level monitoring.
Structured PICO
PPopulationA patient with paroxysmal ventricular tachycardia who experienced a major myocardial infarction, alongside historical reference to 111 cases of atrial fibrillation and flutter.
OOutcomeConversion to normal rhythm
A historical commentary and case report on the long-term use of quinidine for arrhythmias, highlighting its early reported efficacy in converting atrial fibrillation and flutter to normal rhythm.